Arrington Leads Bipartisan Letter Urging U.S. Patent Office to Address Drug Pricing Through Competition
March 28, 2023
March 28, 2023
WASHINGTON, March 28 -- Rep. Jodey Arrington, R-Texas, issued the following news release on March 27, 2023:
Last week, Representative Jodey Arrington (TX-19) joined Reps. Lloyd Doggett (TX-37), Darrell Issa (CA-48), Michael Burgess (TX-26), and Ann Kuster (NH-02) in sending a letter to the U.S. Patent and Trademark Office asking Director Kathi Vidal to consider a policy that supports earlier entry of generic and biosimilar competition into the prescription drug market, which would r . . .
Last week, Representative Jodey Arrington (TX-19) joined Reps. Lloyd Doggett (TX-37), Darrell Issa (CA-48), Michael Burgess (TX-26), and Ann Kuster (NH-02) in sending a letter to the U.S. Patent and Trademark Office asking Director Kathi Vidal to consider a policy that supports earlier entry of generic and biosimilar competition into the prescription drug market, which would r . . .